title: Conversion of Brugada type I to type III and successful control of recurrent ventricular arrhythmia with cilostazol.
authors.affiliation: Department of Cardiology, Ahi Evren Heart and Vascular Surgery Training and Research Hospital, Çamlık Street, 61187 Trabzon, Turkey. Electronic address: tarikagac@gmail.com.
authors.forename: Mustafa Tarık
authors.initials: MT
authors.lastname: Ağaç
authors.affiliation: Department of Cardiology, Ahi Evren Heart and Vascular Surgery Training and Research Hospital, Çamlık Street, 61187 Trabzon, Turkey.
authors.forename: Hakan
authors.initials: H
authors.lastname: Erkan
authors.affiliation: Department of Cardiology, Ahi Evren Heart and Vascular Surgery Training and Research Hospital, Çamlık Street, 61187 Trabzon, Turkey.
authors.forename: Levent
authors.initials: L
authors.lastname: Korkmaz
mesh_terms: D000328:Adult; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D053840:Brugada Syndrome / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D000077407:Cilostazol; D017147:Defibrillators, Implantable; D004554:Electric Countershock / Q000295:instrumentation; D004562:Electrocardiography; D006329:Heart Conduction System / Q000187:drug effects* / Q000503:physiopathology; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D008297:Male; D058987:Phosphodiesterase 3 Inhibitors / Q000627:therapeutic use*; D012008:Recurrence; D017180:Tachycardia, Ventricular / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D013777:Tetrazoles / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000889:Anti-Arrhythmia Agents; D058987:Phosphodiesterase 3 Inhibitors; D013777:Tetrazoles; D000077407:Cilostazol
keywords: Arrhythmia suppression; Brugada syndrome; Cilostazole; Défibrillateur automatique implantable; Implantable cardioverter-defibrillator; Suppression des arythmies; Syndrome de Brugada; Tachycardie ventriculaire; Ventricular tachycardia